130.41 USD
-6.68 (-4.87%)
130.41 USD
0 (0%)
Overall NHC gets a fundamental rating of 6 out of 10. We evaluated NHC against 101 industry peers in the Health Care Providers & Services industry. While NHC has a great profitability rating, there are some minor concerns on its financial health. NHC has a valuation in line with the averages, but on the other hand it scores bad on growth. NHC also has an excellent dividend rating. These ratings would make NHC suitable for dividend investing!
1. Profitability
1.1 Basic Checks
NHC had positive earnings in the past year.
NHC had a positive operating cash flow in the past year.
Each year in the past 5 years NHC has been profitable.
In the past 5 years NHC always reported a positive cash flow from operatings.
1.2 Ratios
NHC has a better Return On Assets (6.71%) than 86.14% of its industry peers.
With a decent Return On Equity value of 10.26%, NHC is doing good in the industry, outperforming 73.27% of the companies in the same industry.
With a decent Return On Invested Capital value of 6.69%, NHC is doing good in the industry, outperforming 65.35% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for NHC is significantly below the industry average of 9.58%.
The 3 year average ROIC (3.68%) for NHC is below the current ROIC(6.69%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.71% | ||
| ROE | 10.26% | ||
| ROIC | 6.69% |
ROA(3y)4.51%
ROA(5y)5.3%
ROE(3y)6.77%
ROE(5y)8.19%
ROIC(3y)3.68%
ROIC(5y)4.6%
1.3 Margins
NHC's Profit Margin of 7.19% is amongst the best of the industry. NHC outperforms 86.14% of its industry peers.
NHC's Profit Margin has improved in the last couple of years.
With a decent Operating Margin value of 7.99%, NHC is doing good in the industry, outperforming 74.26% of the companies in the same industry.
NHC's Operating Margin has improved in the last couple of years.
NHC has a Gross Margin of 38.11%. This is in the better half of the industry: NHC outperforms 67.33% of its industry peers.
In the last couple of years the Gross Margin of NHC has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.99% | ||
| PM (TTM) | 7.19% | ||
| GM | 38.11% |
OM growth 3Y-3.24%
OM growth 5Y5.6%
PM growth 3Y-15.45%
PM growth 5Y2.63%
GM growth 3Y-3.62%
GM growth 5Y-1.28%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so NHC is destroying value.
NHC has more shares outstanding than it did 1 year ago.
The number of shares outstanding for NHC has been increased compared to 5 years ago.
Compared to 1 year ago, NHC has a worse debt to assets ratio.
2.2 Solvency
An Altman-Z score of 4.40 indicates that NHC is not in any danger for bankruptcy at the moment.
NHC has a Altman-Z score of 4.40. This is in the better half of the industry: NHC outperforms 79.21% of its industry peers.
The Debt to FCF ratio of NHC is 0.93, which is an excellent value as it means it would take NHC, only 0.93 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of NHC (0.93) is better than 90.10% of its industry peers.
A Debt/Equity ratio of 0.10 indicates that NHC is not too dependend on debt financing.
The Debt to Equity ratio of NHC (0.10) is better than 75.25% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.1 | ||
| Debt/FCF | 0.93 | ||
| Altman-Z | 4.4 |
ROIC/WACC0.74
WACC9%
2.3 Liquidity
NHC has a Current Ratio of 1.72. This is a normal value and indicates that NHC is financially healthy and should not expect problems in meeting its short term obligations.
NHC's Current ratio of 1.72 is fine compared to the rest of the industry. NHC outperforms 68.32% of its industry peers.
NHC has a Quick Ratio of 1.69. This is a normal value and indicates that NHC is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.69, NHC is in the better half of the industry, outperforming 70.30% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.72 | ||
| Quick Ratio | 1.69 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 13.19% over the past year.
The Earnings Per Share has been growing by 8.03% on average over the past years. This is quite good.
NHC shows a strong growth in Revenue. In the last year, the Revenue has grown by 22.82%.
The Revenue has been growing slightly by 5.58% on average over the past years.
EPS 1Y (TTM)13.19%
EPS 3Y-10.09%
EPS 5Y8.03%
EPS Q2Q%-11.88%
Revenue 1Y (TTM)22.82%
Revenue growth 3Y6.76%
Revenue growth 5Y5.58%
Sales Q2Q%24.7%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 19.44, the valuation of NHC can be described as rather expensive.
Based on the Price/Earnings ratio, NHC is valued a bit cheaper than 70.30% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.51, NHC is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.44 | ||
| Fwd PE | N/A |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of NHC indicates a somewhat cheap valuation: NHC is cheaper than 67.33% of the companies listed in the same industry.
69.31% of the companies in the same industry are more expensive than NHC, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 17.02 | ||
| EV/EBITDA | 11.41 |
4.3 Compensation for Growth
The excellent profitability rating of NHC may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)2.42
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
NHC has a Yearly Dividend Yield of 1.85%.
Compared to an average industry Dividend Yield of 0.60, NHC pays a better dividend. On top of this NHC pays more dividend than 91.09% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.00, NHC has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.85% |
5.2 History
The dividend of NHC has a limited annual growth rate of 3.30%.
NHC has been paying a dividend for at least 10 years, so it has a reliable track record.
NHC has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)3.3%
Div Incr Years11
Div Non Decr Years11
5.3 Sustainability
NHC pays out 35.96% of its income as dividend. This is a sustainable payout ratio.
The dividend of NHC is growing, but earnings are growing more, so the dividend growth is sustainable.
DP35.96%
EPS Next 2YN/A
EPS Next 3YN/A
130.41
-6.68 (-4.87%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners62.45%
Inst Owner Change5.58%
Ins Owners7.08%
Ins Owner Change-0.08%
Market Cap2.02B
Revenue(TTM)1.46B
Net Income(TTM)104.80M
Analysts60
Price TargetN/A
Short Float %2.59%
Short Ratio4.36
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.85% |
Yearly Dividend2.4
Dividend Growth(5Y)3.3%
DP35.96%
Div Incr Years11
Div Non Decr Years11
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.44 | ||
| Fwd PE | N/A | ||
| P/S | 1.39 | ||
| P/FCF | 17.02 | ||
| P/OCF | 13.58 | ||
| P/B | 1.98 | ||
| P/tB | 2.43 | ||
| EV/EBITDA | 11.41 |
EPS(TTM)6.71
EY5.15%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)7.66
FCFY5.88%
OCF(TTM)9.61
OCFY7.37%
SpS93.95
BVpS65.84
TBVpS53.58
PEG (NY)N/A
PEG (5Y)2.42
Graham Number99.7
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.71% | ||
| ROE | 10.26% | ||
| ROCE | 9.01% | ||
| ROIC | 6.69% | ||
| ROICexc | 8.35% | ||
| ROICexgc | 10.23% | ||
| OM | 7.99% | ||
| PM (TTM) | 7.19% | ||
| GM | 38.11% | ||
| FCFM | 8.16% |
ROA(3y)4.51%
ROA(5y)5.3%
ROE(3y)6.77%
ROE(5y)8.19%
ROIC(3y)3.68%
ROIC(5y)4.6%
ROICexc(3y)4.49%
ROICexc(5y)5.97%
ROICexgc(3y)5.54%
ROICexgc(5y)6.99%
ROCE(3y)4.96%
ROCE(5y)6.21%
ROICexgc growth 3Y-4%
ROICexgc growth 5Y11.11%
ROICexc growth 3Y-3.17%
ROICexc growth 5Y7.37%
OM growth 3Y-3.24%
OM growth 5Y5.6%
PM growth 3Y-15.45%
PM growth 5Y2.63%
GM growth 3Y-3.62%
GM growth 5Y-1.28%
F-Score4
Asset Turnover0.93
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.1 | ||
| Debt/FCF | 0.93 | ||
| Debt/EBITDA | 0.64 | ||
| Cap/Depr | 68.45% | ||
| Cap/Sales | 2.07% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 92.81% | ||
| Profit Quality | 113.47% | ||
| Current Ratio | 1.72 | ||
| Quick Ratio | 1.69 | ||
| Altman-Z | 4.4 |
F-Score4
WACC9%
ROIC/WACC0.74
Cap/Depr(3y)68.9%
Cap/Depr(5y)71.13%
Cap/Sales(3y)2.45%
Cap/Sales(5y)2.63%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)13.19%
EPS 3Y-10.09%
EPS 5Y8.03%
EPS Q2Q%-11.88%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)22.82%
Revenue growth 3Y6.76%
Revenue growth 5Y5.58%
Sales Q2Q%24.7%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y63.08%
EBIT growth 3Y3.3%
EBIT growth 5Y11.5%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y219.85%
FCF growth 3Y51.34%
FCF growth 5Y1.58%
OCF growth 1Y136.11%
OCF growth 3Y19.81%
OCF growth 5Y1.4%
NATIONAL HEALTHCARE CORP / NHC FAQ
What is the fundamental rating for NHC stock?
ChartMill assigns a fundamental rating of 6 / 10 to NHC.
Can you provide the valuation status for NATIONAL HEALTHCARE CORP?
ChartMill assigns a valuation rating of 4 / 10 to NATIONAL HEALTHCARE CORP (NHC). This can be considered as Fairly Valued.
How profitable is NATIONAL HEALTHCARE CORP (NHC) stock?
NATIONAL HEALTHCARE CORP (NHC) has a profitability rating of 8 / 10.
How sustainable is the dividend of NATIONAL HEALTHCARE CORP (NHC) stock?
The dividend rating of NATIONAL HEALTHCARE CORP (NHC) is 7 / 10 and the dividend payout ratio is 35.96%.